Liquid nitrogen-treated autograft combined with megaprosthesis versus total femoral replacement for large-volume malignant femoral bone tumors: a comparative study
Authors:
- Nguyen Tran Quang SangNSNguyen Tran Quang Sang
- Nguyen Duc TrungNTNguyen Duc Trung
- Le Duc HuyLHLe Duc Huy
- Luu Huu PhucLuu Huu Phuc
- Vu Duc ThangVTVu Duc Thang
- Luong Nhat AnhLALuong Nhat Anh
- Le The HungLHLe The Hung
- Tran Thi Thu HienTHTran Thi Thu Hien
- Tran Tuyet Thanh HaiTHTran Tuyet Thanh Hai
- Duong Quang VinhDVDuong Quang Vinh
- Tran Van CongTCTran Van Cong
- Nguyen Quoc DatNDNguyen Quoc Dat
Open Access
- 12 August 2026
- journal article
- research article
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 146 (1) , 297
Abstract
Background: Limb-salvage surgery for extensive femoral osteosarcoma presents major reconstructive challenges. Conventional options such as total femoral replacement (TFR) and long-segment biological reconstructions are associated with significant complications. We evaluated the clinical outcomes of a novel hybrid approach combining a liquid nitrogen-treated autograft with a megaprosthesis (LN-MP) and compared them with those of TFR. Materials and methods: This retrospective study included 28 patients (range 8–24 years old) with malignant femoral bone tumors treated between 2020 and 2024. Patients underwent either LN-MP (n = 10) or TFR (n = 18). Perioperative outcomes, functional results (Musculoskeletal Tumor Society score—MSTS), bone union, oncological control, and survival were analyzed. Results: LN-MP demonstrated better functional outcomes (MSTS 27.0 ± 2.1 vs. 24.4 ± 2.2, p = 0.014), shorter operative time, and lower blood loss compared with TFR. Length of stay and follow-up duration were comparable. Continuous disease-free survival was higher in the LN-MP group (90% vs. 44%, p = 0.058), with lower recurrence (10% vs. 28%). Bone union was achieved in 70% of LN-MP cases at a mean of 9 months, with longer graft length associated with delayed union. Conclusions: LN-MP reconstruction may serve as a joint-preserving alternative to total femoral replacement for patients with extensive malignant femoral tumors. In this preliminary series, LN-MP was associated with favorable functional outcomes, satisfactory graft-host bone union, and acceptable oncological results. Given the retrospective design, limited sample size, and short follow-up duration, further studies with larger cohorts and longer follow-up are required to define the role of LN-MP among contemporary limb-salvage reconstructive strategies. Level of evidence: Therapeutic, Level III: retrospective comparative cohort study.Keywords
This publication has 28 references indexed in Scilit:
- Is liquid nitrogen recycled bone and vascular fibula combination the biological reconstruction of choice in lower extremity long bone tumor‐related defects?Journal of Surgical Oncology, 2023
- Limb Salvage and Reconstruction Options in Osteosarcoma2020
- High complication and revision rates after total femoral replacement: a retrospective single center analysis of indication, function, and complicationArchives of orthopaedic and trauma surgery, 2019
- Intercalary frozen autograft for reconstruction of malignant bone and soft tissue tumoursInternational Orthopaedics, 2017
- Total Femur Replacement After Tumor Resection: Limb Salvage Usually Achieved But Complications and Failures are CommonClinical Orthopaedics and Related Research, 2015
- Survival of current production tumor endoprostheses: Complications, functional results, and a comparative statistical analysisJournal of Surgical Oncology, 2013
- Allograft-Prosthetic Composite in the Proximal Tibia After Bone Tumor ResectionClinical Orthopaedics and Related Research, 2008
- Survival after recurrence of osteosarcoma: A 20‐year experience at a single institutionPediatric Blood & Cancer, 2005
- Comparison of two methods of reconstruction for primary malignant tumors at the knee: A sequential cohort studyJournal of Surgical Oncology, 2001
- Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bonesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985